Skip to main content

GOLDMAN SACHS GROUP INC

Position in PRME — Prime Medicine, Inc.

CIK 886982 NEW YORK, NY

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,658,609
+$9,281,532 QoQ
Shares Held
3,430,518
+253.5% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 186 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 99% Shared 1% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. PRME ranks #144 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,658,609 3,430,518
2026-03-31 $3,377,077 970,425
2025-12-31 $6,092,514 1,755,768
2025-09-30 $2,275,477 410,736
2025-06-30 $511,309 207,008
2025-03-31 $500,284 251,399
2024-12-31 $1,231,941 421,898
2024-09-30 $851,957 220,144
2024-06-30 $407,946 79,367
2024-03-31 $267,260 38,180
2023-12-31 $453,180 51,149
2023-09-30 $562,010 58,911